A2A Adenosine Receptors and Equine Sepsis

Award Information
Agency: Department of Agriculture
Branch: N/A
Contract: 2006-33610-17725
Agency Tracking Number: 2003-00471
Amount: $296,000.00
Phase: Phase II
Program: SBIR
Awards Year: 2006
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Adenosine Therapeutics, LLC
1670 Discovery Dr., Ste. 212, Charlottesville, VA, 22911
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Robert Thompson
 (434) 951-9484
 rdt@adenrx.com
Business Contact
 Robert Capon
Title: CEO
Phone: (434) 220-9400
Email: rob@adenrx.com
Research Institution
N/A
Abstract
Endotoxemia (Sepsis) affects horses of all breeds and ages and is the leading causes of death in adult horses and foals. Consequently, its economic impact on the equine industry in the United States is devastating. This project seeks to develop new treatments for this disease.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government